Weekly Signals Desk | Concentrated Analyst Revisions via the FMP API (Oct 26-30)

This week's screen counted 23 rating changes across five names, and 21 of them were downgrades. The tally looks one-sided, but the causes are not. Nine of those cuts at Instacart are the mechanical result of a takeover price capping the shares. The remaining downgrade clusters, at Boston Scientific, Reddit and Alkami Technology, have a common thread that matters more than the direction: analysts are losing visibility on how growth gets rebuilt, not just trimming targets after a soft quarter. The only upgrades came from Dr. Reddy's Laboratories, where two long-standing bears moved to the sidelines.

Using FMP's Stock News API alongside the Stock Grades API, this edition looks at what drove each cluster, which part of the analyst model was rewritten, and how revision data can be structured into a repeatable research workflow.

Key Takeaways

• Instacart's nine downgrades are a deal reaction: with an agreed offer from DoorDash at $65 per share, analysts moved targets to the offer price and removed upside cases.
• Boston Scientific, Reddit and Alkami all beat or met some near-term metrics but lost ratings on uncertainty about the path back to growth, a different kind of signal than an earnings miss.
• Reddit's cluster stands out because analysts are questioning user durability itself, linked to falling search referrals, while monetization remains strong.
• Dr. Reddy's upgrades were valuation and risk-balance calls after a long period of underperformance, not a shift to a bullish stance.

Subscribe to FMP on Substack

Where Analyst Conviction Shifted This Week

Instacart (CART) - 9 Downgrades

Instacart received nine downgrades after announcing a definitive agreement to be acquired by DoorDash for $65 per share, with at least 75% of the consideration in cash and the remainder in DoorDash stock, subject to shareholder elections. Wedbush, Needham, Barclays, Citizens, Raymond James, Cantor Fitzgerald, Bernstein, Jefferies and Baird all moved to neutral-equivalent ratings. Where targets were kept, they converged on $65, and several firms removed targets entirely. The third-quarter results released alongside the deal were solid, with gross transaction value, revenue and adjusted EBITDA modestly ahead of consensus, and guidance was suspended.

The signal here is about the ceiling, not the business. Several analysts noted that operating momentum was among the strongest since the IPO, with transaction value growth accelerating for a third straight quarter and advertising revenue the standout. That is precisely why the cluster carries little information about Instacart's fundamentals: the downgrades reflect that an agreed price now defines most of the remaining upside. Analysts also flagged a low probability of a competing bid, given the break fee owed to DoorDash and reports that another potential buyer had withdrawn.

From here, the relevant variables are deal mechanics rather than quarterly execution. The spread between the share price and the blended offer value, the regulatory review timeline, with closing expected in late 2027 or the first half of 2028, and the value of the stock component as DoorDash shares move will drive returns. FMP's Search Mergers & Acquisitions API records the transaction details, and the Price Target Consensus API shows how quickly the analyst target range compressed around the offer.

Boston Scientific Corporation (BSX) - 4 Downgrades

Boston Scientific was downgraded by Oppenheimer, TD Cowen, JPMorgan and Jefferies after a third quarter that fell short of the company's own guidance and an outlook that set expectations for very little growth in 2027. Oppenheimer moved from Outperform to Perform, describing an unusually sharp boom and bust cycle and a credibility gap on execution. TD Cowen shifted from Buy to Hold and cut its target from $56 to $46, JPMorgan moved from Overweight to Neutral, and Jefferies went from Buy to Hold.

The core issue is that two of the company's flagship growth franchises are now shrinking. Sales in the left atrial appendage closure business and in electrophysiology both declined in the quarter, with management pointing to competitive pressure in pulsed field ablation and weaker standalone procedure volumes. A cybersecurity incident also disrupted operations for several business days, which management estimated cost roughly three points of growth. Management described 2027 as the trough of the current cycle, with recovery expected from 2028 and a restructuring program targeting more than $500 million in savings over three years.

What makes this cluster important is the time horizon. Analysts are not debating one quarter; they are questioning when growth can resume and whether cost cuts can protect earnings in the meantime. The data suggests this may be an area to monitor through franchise-level sales trends and the timing of next-generation product launches. FMP's Revenue Product Segmentation API isolates the declining franchises from the businesses still growing double digits, and the Financial Estimates API shows how far 2027 and 2028 earnings expectations have moved.

Alkami Technology Inc. (ALKT) - 4 Downgrades

Alkami Technology drew four downgrades after mixed third-quarter results. Citizens moved from Market Outperform to Market Perform, Craig-Hallum from Buy to Hold with a $16 target, KeyBanc from Overweight to Sector Weight, and William Blair from Outperform to Market Perform. Revenue grew faster than the prior quarter and adjusted EBITDA beat, but annual recurring revenue came in below consensus and its growth rate slowed.

The split between revenue and recurring revenue is the key detail. Part of the quarter's revenue strength came from a one-time item that shifted between quarters, while the forward-looking measure of contracted business decelerated. For a digital banking software provider selling into credit unions and regional banks, recurring revenue is the clearest indicator of new sales activity. William Blair captured the general view: the shares are likely to stay range-bound until investors gain confidence in new bookings and the prospects for faster growth. Management has also deferred 2027 guidance until its fourth-quarter report.

This is a visibility downgrade rather than a quality downgrade. Margins are improving and full-year guidance was nudged up, but the sales pipeline is what determines whether growth re-accelerates. FMP's Key Metrics TTM API can track revenue per client and margin progression, while the Earnings Report API places the next report against estimates once 2027 guidance is issued.

Reddit, Inc. (RDDT) - 4 Downgrades

Reddit received four downgrades after a third quarter in which revenue grew strongly and margins expanded, but user metrics weakened. Evercore ISI moved from Outperform to In Line and cut its target from $265 to $120, removing its tactical outperform call. Oppenheimer moved from Outperform to Perform, KeyBanc from Overweight to Sector Weight, and Citizens from Market Outperform to Market Perform.

Analysts are separating two parts of the business that had previously moved together. Advertising execution remains strong, with fourth-quarter guidance implying continued high growth and wider margins. The concern is the top of the funnel. U.S. daily active users declined, and management warned that global daily users could fall by a low double-digit percentage in the fourth quarter if search referrals keep shrinking at October's pace. Several firms tied this to changes in how search engines surface results as AI-generated answers expand, which they see as potentially structural. Reddit plans to test a logged-in experience, which may improve long-term engagement but could raise marketing costs and slow new user growth.

The signal is a shift in which assumption drives valuation. Monetization per user has been doing the heavy lifting, and analysts are now asking whether it can continue to offset a shrinking or stagnant user base. Daily active user trends by geography, revenue per user, and the cost of the logged-in transition are the variables to monitor. FMP's Earnings Transcript API captures management's commentary on traffic sources, and the Financial Estimates API shows how far 2027 revenue and EBITDA forecasts have been reduced.

Dr. Reddy's Laboratories Ltd. (RDY) - 2 Upgrades

Dr. Reddy's was upgraded by Jefferies, from Underperform to Hold with a target raised from INR1,040 to INR1,320, and by JPMorgan, from Underweight to Neutral with a target raised from INR1,100 to INR1,270. Both upgrades followed fiscal second-quarter results in which EBITDA and adjusted core margins beat expectations despite revenue that was in line or slightly below, helped by strength in India and emerging markets and lower-than-normal R&D spending.

Neither firm turned bullish. Both cited limited downside after a long period of relative underperformance following the loss of exclusivity on a major generic, and both raised earnings estimates on better margins in the base business. The catalysts they flagged are specific: the planned resumption of semaglutide supplies in November and a potential U.S. approval for a biosimilar of abatacept in December. JPMorgan remained cautious on the semaglutide ramp and on abatacept execution, and noted that R&D spending was below normal levels, raising questions about margin durability.

This is a reduction in conviction on the bear case rather than the start of an upgrade cycle. The data suggests the next two months may clarify whether those product events translate into earnings, which is when estimate revisions would become more informative. FMP's Historical Stock Grades API shows how long the underweight stance had been in place, and the Income Statement API helps test whether margin gains are coming from operations or from temporarily lower R&D.

Reading the Revision Clusters Beneath the Headlines

The week's numbers point heavily in one direction, but the content of the revisions shows three separate dynamics. Instacart is a deal reset, where downgrades reflect a capped price rather than any change in the underlying business. Boston Scientific, Reddit and Alkami form a second group, where analysts revised the assumption that matters most for valuation: when growth resumes at Boston Scientific, whether users hold at Reddit, and whether new bookings accelerate at Alkami. Dr. Reddy's is the third, a move from negative to neutral driven by valuation and a set of near-term product catalysts.

What links the middle group is that each company delivered some good news. Boston Scientific has businesses growing double digits, Reddit's monetization remains strong, and Alkami beat on revenue and EBITDA. Analysts downgraded anyway because the visible part of the model, the current quarter, is no longer the part that determines value. When the debate moves from execution to visibility, revision clusters tend to persist until new evidence arrives, which makes the timing of the next data points, such as product launches, user metrics or guidance, more important than the size of any single target cut.

A stronger screen therefore classifies revisions by cause before ranking them by count. The Stock Grades API shows how many firms moved together, while the Price Target Consensus API measures the size and spread of the valuation reset; for Instacart, that spread collapsed around the offer, while for Reddit it widened. The Financial Estimates API then shows whether the downgrades have flowed into revenue and earnings forecasts or remain a rating-level change.

Reported fundamentals are the final check. Comparing revisions with the Income Statement API and Revenue Product Segmentation API helps distinguish a franchise-specific slowdown, as at Boston Scientific, from a broader deterioration. For names where commentary drives the debate, the Earnings Transcript API adds management's explanation of what changed. Combining these sources within the FMP data ecosystem turns a list of downgrades into a map of which assumptions are under pressure, and which developments would need to occur before those assumptions can be tested against results.

Turning Analyst Revisions Into a Structured Research Workflow

Analyst ratings only become actionable when you stop treating them as isolated headlines and start handling them as structured data. The goal is straightforward: capture changes as they happen, standardize them, and then connect those changes back to real-world events. Before anything else, make sure your API key is active and ready to run.

1. Pull Latest Analyst Ratings

Begin with a fresh pull from the Stock News API. This endpoint aggregates recent market-moving headlines, including upgrades and downgrades. It's the fastest way to establish a baseline of who changed their view and when, without needing to scrape multiple sources.

Endpoint:

https://financialmodelingprep.com/stable/news/stock-latest?page=0&limit=20&apikey=YOUR_API_KEY

Sample Response:

[ { "symbol": "INSG", "publishedDate": "2025-02-03 23:53:40", "publisher": "Seeking Alpha", "title": "Q4 Earnings Release Looms For Inseego, But Don't Expect Miracles", "image": "...", "site": "seekingalpha.com", "text": "Inseego's Q3 beat was largely due to a one-time debt restructuring gain, not sustainable earnings growth, raising concerns about future performance. The sale of its telematics business for $52 million allows INSG to focus on North America, but it remains to be seen if this was wise. Despite improved margins and reduced debt, Inseego's revenue growth is insufficient, and its high stock price remains unjustifiable for new investors.", "url": "https://seekingalpha.com/article/4754485-inseego-stock-q4-earnings-preview-monitor-growth-margins-closely" } ]

2. Isolate Rating Changes

From that initial feed, filter for entries that explicitly reference upgrades or downgrades. This step is about narrowing the universe—identifying which tickers are actually seeing analyst activity versus general news flow. Once you have that subset, you're ready to move from raw headlines to structured tracking.

3. Quantify the Activity

For each ticker identified, call the Stock Grades API to retrieve the latest analyst actions tied specifically to that name. This is where the workflow shifts from collection to measurement.

Group the results by ticker and separate upgrades from downgrades. Single mentions tend to be incidental; repeated actions across multiple firms indicate something more deliberate. This aggregation step is what surfaces clusters—names where sentiment is actively being recalibrated.

4. Map the Catalyst

Once the high-activity names are clear, the next step is attribution. Use the Search Stock News API to pull company-specific headlines and align rating changes with underlying developments—earnings releases, M&A announcements, regulatory updates, or sector-wide shifts.

Endpoint:

https://financialmodelingprep.com/stable/news/stock?symbols=AAPL&apikey=YOUR_API_KEY

Example Workflow: Finding the “Most Active” Stocks

1. Pull a rolling seven-day window of headlines from the Stock News API and filter for upgrades/downgrades.
2. Extract tickers that appear at least once with a rating change.
3. For each ticker, query the Stock Grades API to retrieve the full set of recent analyst actions.
4. Count total upgrades and downgrades per name.
5. Prioritize tickers with three or more revisions (or another threshold aligned with your coverage).
6. Run those tickers through the Search Stock News API to line up rating shifts with the underlying catalyst.

Scaling Analyst Workflows Across the Organization

Workflows built around analyst revisions rarely remain isolated for long once they begin producing repeatable signal quality. Inside most firms, the transition usually starts when a handful of analysts consistently surface actionable sentiment shifts earlier than the broader desk — not because they have access to different information, but because their process for structuring and contextualizing that information is more systematic. Over time, those workflows tend to move from individual notebooks and spreadsheets into shared operating infrastructure.

That evolution changes the role of the data itself. Analyst revisions stop functioning as scattered research notes and become part of a governed internal framework that can be referenced across research, portfolio management, and risk teams simultaneously. Centralized dashboards replace duplicated manual tracking, standardized query logic reduces interpretation drift between teams, and structured datasets create an audit trail around how sentiment changes were identified and interpreted. The operational benefit is not simply speed — it is consistency. When multiple desks are evaluating the same revision clusters against the same underlying financial and market data, internal discussions become materially less fragmented.

In practice, analysts often become the internal champions driving that standardization effort. After pressure-testing workflows across multiple earnings cycles, they begin codifying the inputs that proved most reliable: revision velocity, estimate changes, target dispersion, earnings transcript language, sector-relative performance, and catalyst alignment. Once standardized, those inputs become reusable across broader coverage universes rather than dependent on individual institutional knowledge. That continuity becomes increasingly important as coverage rotates, teams expand, or macro conditions force firms to reevaluate exposure across sectors quickly.

Infrastructure becomes increasingly relevant at that stage because scaling a workflow across teams requires more than simply increasing API usage. The underlying data pipelines, timestamps, outputs, and revision histories need to remain consistent and traceable across users and mandates. The Financial Modeling Prep Enterprise plan tend to fit into this layer less as standalone data products and more as centralized coordination systems — enabling firms to maintain shared reference frameworks as analyst sentiment, earnings revisions, and positioning data evolve over time.

Get your free API key

When the Analyst Framework Starts to Move

The most useful revision clusters are the ones that reveal which assumption analysts no longer trust, and this week that assumption was visibility more often than valuation. Following those shifts through FMP's Stock News API and Stock Grades API keeps the focus on the evidence that will eventually confirm or reverse them.

For additional trading ideas backed by data, explore: Weekly Signals Desk | Price-Target Gaps Identified via the FMP API (Oct 19-23)

Disclosure: Signals Desk content is provided for informational and analytical purposes only and does not constitute investment advice or trade recommendations. The analysis reflects interpretation of market data and publicly disclosed or third-party information, including data accessed via Financial Modeling Prep APIs, at the time of publication. Signals discussed are probabilistic, can be wrong, and may change as market conditions and consensus data evolve. This content should be considered alongside broader research, individual objectives, and risk assessment.